| Literature DB >> 34850062 |
Daniel DiMaio1,2,3,4, Brinda Emu4,5, Andrew L Goodman4,6, Walther Mothes4,6, Amy Justice4,7.
Abstract
Microbes play important roles in cancer from direct carcinogenic effects to their use in treatment. Cancers caused by microorganisms account for approximately 15% of cancers, primarily in low- and middle-income countries. Unique features of infectious carcinogens include their transmissibility, mutability, and specific immune interactions, which provide challenges and opportunities for cancer prevention and treatment. For these agents, infection control through exposure reduction, antivirals, antibiotics, and vaccines is cancer control. In addition, developing evidence suggests that microorganisms including the human microbiome can indirectly modulate cancer formation and influence the effectiveness and toxicity of cancer treatments. Finally, microorganisms themselves can be used to prevent or treat cancer. The convergence of these factors signals the emergence of a new field, cancer microbiology. Recognition of cancer microbiology will spur research, stimulate cross-disciplinary training, inform drug development, and improve public health.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34850062 PMCID: PMC9086797 DOI: 10.1093/jnci/djab212
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 11.816